Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 2/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 5/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2285801 | 0.86 | MAPT (0.56) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL7117627 | 0.86 | MAPT (0.47) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL1401309 | 0.85 | MAPT (0.56) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL3392995 | 0.85 | MAPK1 (0.65) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL3712813 | 0.85 | MAPT (0.50) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL4816642 | 0.85 | MAPT (0.50) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL13415721 | 0.85 | MAPT (0.50) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL1071033 | 0.85 | MAPK1 (0.65) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL6906747 | 0.85 | MAPT (0.50) | MAPTMAPK1PRKCAPRKCDPRKCE | |
| SCHEMBL6904773 | 0.85 | MAPT (0.50) | MAPTMAPK1PRKCAPRKCDPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7459581-B2 | Anti-bacterial compounds | GIVAUDAN S.A. (CH) | 2008-12-02 | — | — | US | claimed |
| US-20080070985-A1 | Anti-Bacterial Compounds | BEIERSDORF AG (DE) | 2008-03-20 | — | — | US | claimed |
| EP-1786756-A1 | ANTI-BACTERIAL COMPOUNDS | Givaudan SA (CH) | 2007-05-23 | — | — | EP | claimed |
| WO-2006026876-A1 | ANTI-BACTERIAL COMPOUNDS | GIVAUDAN SA (CH) | 2006-03-16 | — | — | WO | claimed |
| US-20140287361-A1 | RESIST COMPOSITION AND RESIST PATTERN FORMING METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| US-20140287361-A1 | RESIST COMPOSITION AND RESIST PATTERN FORMING METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2014-09-25 | — | — | US | disclosed |
| US-7459581-B2 | Anti-bacterial compounds | GIVAUDAN S.A. (CH) | 2008-12-02 | — | — | US | disclosed |
| US-20080070985-A1 | Anti-Bacterial Compounds | BEIERSDORF AG (DE) | 2008-03-20 | — | — | US | disclosed |
| EP-1786756-A1 | ANTI-BACTERIAL COMPOUNDS | Givaudan SA (CH) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006026876-A1 | ANTI-BACTERIAL COMPOUNDS | GIVAUDAN SA (CH) | 2006-03-16 | — | — | WO | disclosed |
| US-5015419-A | Bactericides or fungicides and yarn lubricants for textiles | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1991-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070985-A1 | Anti-Bacterial Compounds | H1-0, H1-3, LBR | MAPT 4634/4885MAPK1 1717/4885PRKCA 4373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.